This article was originally published on Fool.com
When most investors think about marijuana stocks, one like Canopy Growth Corporation(NYSE:CGC) probably comes to mind. The company cultivates and produces cannabis products, including flower and oils. But while The Scotts Miracle-Gro Company (NYSE:SMG)is still best known for its consumer lawn and garden products, it too has become a marijuana stock by emerging as the leading supplier to the U.S. cannabis industry.
There’s no contest between these two stocks when it comes to year-to-date performance. Canopy Growth is up close to 80%. Scotts is down more than 25%. But which of these stocks is the better choice for long-term investors?
The case for Canopy Growth
Any argument about the merits of investing in Canopy Growth has to start with the tremendous growth opportunity for the global cannabis industry. Countries around the world have legalized medical marijuana. Canada and Uruguay have legalized recreational marijuana, along with 10 U.S. states plus the District of Columbia. Some project that the global marijuana market will top $100 billion and perhaps a lot more within the next 15 years.
Canopy Growth appears to be in the best position of any company to capitalize on this market. It currently has 4.3 million square feet of licensed growing space in Canada. With its subsidiaries, Canopy claims a whopping 5.6 million square feet of growing space.
Production capacity is one key to success for Canopy Growth. Its distribution channels are another. Canopy lined up supply agreements for the recreational marijuana market in all of Canada’s provinces and territories that have announced supply plans. The company is moving forward aggressively with its retail strategy as well.
Earlier this year, major alcoholic-beverage company Constellation Brands invested $4 billion in Canopy Growth, boosting its stake in Canopy to 38% with an option to acquire even more shares. This deal solidified Canopy Growth’s status as the leading player in the cannabis industry and gave the company a big cash stockpile to expand its operations. Constellation Brands and Canopy Growth plan to launch cannabis-infused beverages in Canada when regulations are finalized for these types of products.
Canopy Growth already has a presence in multiple international medical marijuana markets, including Australia, South America, Africa, and Europe, particularly in Germany. The company is poised to enter any other countries with federal laws that allow the legal sales of marijuana.
The case for Scotts Miracle-Gro
Growth for the global cannabis industry is also a key part of the investing thesis for Scotts Miracle-Gro. But the focus for Scotts is on the U.S. market.
That’s actually a big plus for Scotts. The U.S. currently generates roughly 85% of total legal marijuana sales worldwide. That percentage will decline somewhat over the next few years as the markets in other countries expand. But the U.S. will continue to be the big prize for marijuana businesses for a long time to come.
Thanks to a string of acquisitions, Scotts Miracle-Gro has become the go-to supplier for U.S. marijuana growers. The company’s Hawthorne Gardening subsidiary provides a wide range of products, including fertilizers, hydroponics, lighting systems, irrigation systems, and ventilation systems.
Hawthorne Gardening makes the lion’s share of its money now in California. That’s not surprising, since it’s the largest marijuana market in the U.S. by far. However, the company has tremendous growth potential in other states — especially those that legalize recreational marijuana.
Still, Scotts Miracle-Gro’s marijuana-focused business generates only around 8% of the company’s total revenue. The rest comes from its core lawn and garden business. Scotts is launching new products and raise prices in 2019, moves that should boost its revenue. And with warmer weather conditions likely in future years, the company’s lawn and garden sales could enjoy solid growth.
There’s one more reason for investors to like Scotts Miracle-Gro as well — its dividend. Scotts’ dividend currently yields 3.11%, a nice bonus on top of the company’s growth prospects.
If you’re a more conservative investor, Scotts Miracle-Gro is probably the better pick for you. The company generates a steady cash flow, it’s profitable, and it pays out a solid dividend.
On the other hand, more aggressive growth investors will probably like Canopy Growth. If the global marijuana market gets anywhere close to the levels many expect, Canopy will skyrocket. The major downside for Canopy Growth is that its valuation already assumes a lot of growth. Should anything arise that derails the company’s growth trajectory, its stock would almost certainly plunge.
But trading off risk for reward comes with the territory for investors. For those who don’t want to take on as much risk, go with Scotts Miracle-Gro. For investors comfortable with higher levels of risk, consider Canopy Growth. Both marijuana stocks should be winners over the long run.
Cannabis Stocks: Get Ready for ‘Green Rush’!
On 17th October 2018, recreational cannabis use became legal across the whole of Canada — ushering in a new era of legitimacy for the country’s burgeoning multi-billion-dollar marijuana industry.
But how can you aim to profit from this sector’s huge potential… while reducing the risk of seeing your cannabis investments ‘go up in smoke’?
The Motley Fool’s leading cannabis sector analyst has put together this timely special report for UK investors that explains how to get started and reveals one cannabis stock that we think you’ll want to avoid!